Crinetics Pharmaceuticals (CRNX) Net Margin (2017 - 2025)
Historic Net Margin for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to 90972.73%.
- Crinetics Pharmaceuticals' Net Margin changed N/A to 90972.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 27537.2%, marking a year-over-year decrease of 12604900.0%. This contributed to the annual value of 28625.51% for FY2024, which is 234131500.0% down from last year.
- According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Net Margin is 90972.73%.
- In the past 5 years, Crinetics Pharmaceuticals' Net Margin ranged from a high of 1074.23% in Q1 2022 and a low of 90972.73% during Q3 2025
- Moreover, its 5-year median value for Net Margin was 9641.23% (2022), whereas its average is 16168.04%.
- Data for Crinetics Pharmaceuticals' Net Margin shows a peak YoY increase of 73389500bps (in 2025) and a maximum YoY decrease of -164058100bps (in 2025) over the last 5 years.
- Crinetics Pharmaceuticals' Net Margin (Quarter) stood at 2857.88% in 2021, then crashed by -125bps to 6438.93% in 2022, then tumbled by -153bps to 16302.89% in 2023, then decreased by -14bps to 18556.89% in 2024, then plummeted by -390bps to 90972.73% in 2025.
- Its Net Margin stands at 90972.73% for Q3 2025, versus 11217.94% for Q2 2025 and 26750.97% for Q1 2025.